ASX Share rice
Fri 14 May 2021 - 09:12:pm (Sydney)

NYR Share Price

NYRADA INC.NYRPharmaceuticals, Biotechnology & Life Sciences

NYR Company Information

Name:

Nyrada Inc

Sector:

Healthcare

Industry:

Biotechnology

Address:

828 Pacific Highway Gordon NSW Australia 2072

Phone:

61 2 9053 1990

Chief Exec. Officer:

Mr. James Bonnar

Chief Financial Officer:

Mr. Cameron Jones C.A.

Chief Scientific Officer:

Mr. Benjamin Evison Ph.D.

Sr. VP of US Operations:

Mr. Mark Waring B.Sc., P.M.P.

Company Sec.:

Mr. David James Franks B.Ec, BEc, CA, F Fin, JP.

Company Overview:

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury; a drug to treat pain associated with peripheral nerve damage; and a drug to treat autoimmune diseases, such as psoriasis. Nyrada Inc. has collaboration with Walter Reed Army Institute of Research and UNSW. The company was founded in 2017 and is based in Gordon, Australia.

NYR Share Price Information

Shares Issued:

138.53M

Market Capitalisation:

$41.56M

Revenue (TTM):

$1.18M

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.0528

Operating Margin (TTM):

$-5.17

Return On Assets (TTM):

$-1.52

Return On Equity (TTM):

$-20.18

Quarterly Revenue Growth (YOY):

1.314

Gross Profit(TTM):

$-274,585

Diluted Earnings Per Share (TTM):

$-0.057

NYR CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-2,999

Change To Liabilities:

$68.34K

Total Cashflow From Investing Activities:

$-2,999

Net Borrowings:

$689.38K

Net Income:

$-5,773,667

Total Cash From Operating Activities:

$-4,410,623

Depreciation:

$1.48K

Change To Account Receivables:

$-1,078,839

Sale Purchase Of Stock:

$8.70M

Capital Expenditures:

$3K

NYR Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-5,773,670

Net Income:

$-5,773,670

Operating Income:

$-5,683,320

Other Operating Expenses:

$219.39K

Interest Expense:

$140.36K

Total Revenue:

$1.08M

NYR Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$37K

Total Liabilities:

$740.67K

Total Stockholder Equity:

$5.53M

Other Current Liabilities:

$6.39K

Total Assets:

$6.27M

Common Stock:

$15.61M

Retained Earnings:

$-12,285,073

Cash:

$5.15M

Total Current Liabilities:

$740.67K

Property - Plant & Equipment:

$5.25K

Net Tangible Assets:

$5.49M

Total Current Assets:

$6.23M

Net Receivables:

$1.08M

Short-Term Investments:

$42.25K

Accounts Payable:

$209.64K

Short-Term Investments:

$42.25

Non Current Liabilities Total:

$0

NYR Share Price History

NYR News

23 Feb, 2021
Just because a business does not make any money, does not mean that the stock will go down. For example, although...